Vitamin D3 for Life

Live Enlightened

Physiology

Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Study Summary

Previous related pageVitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Full StudyNext related pageVitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Full Study
Study at a glance

Can active vitamin D change how immune cells attach to blood-vessel linings?

Two studies used human blood-vessel lining cells grown in the laboratory to examine responses to an inflammatory signal. They tested active vitamin D, not ordinary vitamin D3 supplements taken by people. One study measured molecules that help immune cells interact with the lining. The other measured immune-cell attachment itself.

Did active vitamin D change molecules involved in immune-cell attachment?

Active vitamin D given before the inflammatory signal reduced two attachment-related molecules. Reducing the vitamin D receptor, the protein that receives vitamin D signals, weakened some responses. However, one result did not fit the simple explanation proposed for how the receptor worked. The study therefore suggests a possible mechanism with an unresolved inconsistency. It did not directly demonstrate less immune-cell attachment.

Did active vitamin D reduce actual immune-cell attachment?

Researchers combined vessel-lining cells with a laboratory line of immune cells and counted attachment using fluorescent labels. Active vitamin D did not significantly reduce attachment when given with the inflammatory signal or after it had begun. There were three independent experiments with repeated measurements. Measurements of molecules in the surrounding liquid did not directly show how much was present on the cell surface.

Do these cell studies show better blood flow or fewer heart attacks?

The experiments differed in timing, strength of the inflammatory challenge and what they measured. They did not establish which difference explained the contrasting results. No significant attachment reduction does not prove that every small effect is absent, but it also does not demonstrate benefit. Neither study measured better blood flow, fewer heart attacks or fewer strokes. They do not establish a supplement dose, blood target or protection for the heart and blood vessels.

Read the full article below ↓

Two 2025 cell studies examined whether the active vitamin D hormone changes inflammatory interactions at the blood-vessel lining. One reported lower expression of selected adhesion molecules, with an important inconsistency in its proposed receptor mechanism. The other measured immune-cell attachment directly and found no significant reduction. For the detailed methods and appraisal, read Vitamin D, Endothelial Inflammation and Immune-Cell Adhesion: Full Study.

What the positive experiment measured

Xia and colleagues studied human umbilical vein endothelial cells in culture. They used calcitriol, the active vitamin D hormone, rather than ordinary oral vitamin D3. After stimulation with tumour necrosis factor alpha, an inflammatory messenger, calcitriol pretreatment reduced expression of vascular cell adhesion molecule 1 and E-selectin. These are molecules involved in interactions between immune cells and the vessel lining.

This addressed one part of endothelial function. It did not directly show fewer immune cells attaching, a stronger vessel barrier or fewer cardiovascular events. Reducing vitamin D receptor expression weakened some reported responses. However, Figure 3’s result for nuclear p65, a component of an inflammatory gene-regulation system, does not follow the simple receptor-dependent account. The mechanism therefore needs qualification and clarification.

What the functional adhesion experiment found

Marino and colleagues combined endothelial cells with a laboratory monocyte cell line. Monocytes are immune cells that circulate in blood. The researchers measured attachment using labelled cells and fluorescence after washing away cells that had not adhered. Calcitriol did not significantly reduce attachment when given with the inflammatory stimulus or after stimulation had begun.

The adhesion analyses involved three independent experiments, with repeated technical measurements. This was not a clinical trial. The researchers also measured soluble adhesion-related markers in culture liquid; these do not directly establish the amount of protein displayed on the cell surface. A dose-unit discrepancy in the viability methods is a further reporting limitation.

Why the findings differ without proving a single explanation

The experiments used different inflammatory stimulus strengths, treatment schedules, culture histories and endpoints. The inflammatory signalling overview explains why those conditions matter. A molecular response in one protocol does not guarantee a functional adhesion response in another. The studies did not test which difference explained the contrasting findings.

A null result means no statistically established reduction under the tested conditions. It does not exclude every smaller effect or every other biological setting. Equally, possible explanations for a null finding are not evidence that a benefit actually occurred. Both the positive observations and their limitations belong in the interpretation.

What this means for cardiovascular claims

Neither paper measured blood flow or vascular tone, the contraction and relaxation of vessel walls. Neither tested heart attacks, strokes or atherosclerotic plaque progression in people. Adhesion-related signalling is a candidate risk pathway, not a validated substitute for those outcomes.

The evidence supports further investigation of specific endothelial mechanisms. It does not establish that taking vitamin D prevents cardiovascular disease, define a supplement dose or identify an optimal blood concentration. The active hormone used in a culture dish must not be treated as interchangeable with nutritional supplementation.

Scientific sources

Xia Y, Liu S, Shao Q, Feng Y, Jin B, Zhang Q. 1α, 25-dihydroxyvitamin D3 attenuates tumor necrosis factor-α-induced endothelial cell injury by modulating the tumor necrosis factor-α/nuclear factor kappa-B pathway. CytoJournal. 2025;22:70. DOI: 10.25259/Cytojournal_220_2024. PMID: 41216236. Endothelial signalling experiment; interpret the receptor mechanism with the reporting qualifications discussed above.

Marino M, Venturi S, Møller P, Rendine M, Martini D, Riso P, Del Bo’ C. Vitamin D does not mitigate monocyte adhesion to vascular endothelial cells in an in vitro pro-inflammatory model. PharmaNutrition. 2025;34:100454. DOI: 10.1016/j.phanu.2025.100454. The university record identifies the publication and links its published version; the complete author-uploaded article was also examined.

Related reading

Physiology

Vitamin D and Cytokine Balance

Explains how vitamin D relates to cytokine balance, including immune-cell communication, pro: and anti-inflammatory signalling, tissue-specific responses, and resolution biology, without making treatment claims.

Read more →

Original sources

Source

1α, 25-dihydroxyvitamin D3 attenuates tumor necrosis factor-α-induced endothelial cell injury by modulating the tumor necrosis factor-α/nuclear factor kappa-B pathway

Published in CytoJournal (2025).

Publication details

Xia Y, Liu S, Shao Q, Feng Y, Jin B, Zhang Q. 1α, 25-dihydroxyvitamin D3 attenuates tumor necrosis factor-α-induced endothelial cell injury by modulating the tumor necrosis factor-α/nuclear factor kappa-B pathway. CytoJournal. 2025;22:70. DOI: 10.25259/Cytojournal_220_2024. PMID: 41216236. Endothelial signalling experiment; interpret the receptor mechanism with the reporting qualifications discussed above.

Read more →
Source

Vitamin D does not mitigate monocyte adhesion to vascular endothelial cells in an in vitro pro-inflammatory model

Published in PharmaNutrition (2025).

Publication details

Marino M, Venturi S, Møller P, Rendine M, Martini D, Riso P, Del Bo’ C. Vitamin D does not mitigate monocyte adhesion to vascular endothelial cells in an in vitro pro-inflammatory model. PharmaNutrition. 2025;34:100454. DOI: 10.1016/j.phanu.2025.100454. The university record identifies the publication and links its published version; the complete author-uploaded article was also examined.

Read more →